Vincent Sobanski

2.8k citations

77 papers · 1.3k · h-index 20

Impact in

Pathology and Forensic Medicine top 1%
- Systemic Sclerosis and Related Diseases
- Autoimmune Bullous Skin Diseases
Dermatology top 2%
- Dermatologic Treatments and Research

Papers in

Pathology and Forensic Medicine 55
- Systemic Sclerosis and Related Diseases 50
- Autoimmune Bullous Skin Diseases 8
Epidemiology 26
- Inflammatory Myopathies and Dermatomyositis 23

Co-authors: David Launay (61 shared papers)É. Hachulla (56 shared papers)Pierre‐Yves Hatron (16 shared papers)Marc Humbert (6 shared papers)M. Lambert (21 shared papers)Guillaume Lefèvre (11 shared papers)Sylvain Dubucquoi (26 shared papers)Luc Dauchet (4 shared papers)
Journals: Frontiers in Immunology (5 papers)PLoS ONE (5 papers)Autoimmunity Reviews (4 papers)Arthritis & Rheumatology (4 papers)Arthritis Research & Therapy (3 papers)
Partner nations: France United States Germany

In The Last Decade

Vincent Sobanski

64 papers receiving 1.3k citations

Peers

Countries citing papers authored by Vincent Sobanski

Since Specialization

Citations

This map shows the geographic impact of Vincent Sobanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Sobanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Sobanski more than expected).

Fields of papers citing papers by Vincent Sobanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Sobanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Sobanski. The network helps show where Vincent Sobanski may publish in the future.

Co-authors

The 25 scholars most cited alongside Vincent Sobanski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Sobanski Line = papers co-authored together Vincent Sobanski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Survival and Prognostic Factors in Systemic Sclerosis–Associated Pulmonary Hypertension: A Systematic Review and Meta‐Analysis Arthritis & Rheumatism ·Guillaume Lefèvre, Luc Dauchet, É. Hachulla, David Montani, Vincent Sobanski, M. Lambert, Pierre‐Yves Hatron, Marc Humbert, David Launay	2013	186
2	Pulmonary hypertension in systemic sclerosis: different phenotypes European Respiratory Review ·David Launay, Vincent Sobanski, É. Hachulla, Marc Humbert	2017	89
3	Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis Arthritis & Rheumatology ·Vincent Sobanski, Jonathan Giovannelli, Yannick Allanore, Gabriela Riemekasten, Paolo Airó, Serena Vettori, Franco Cozzi, Oliver Distler, Marco Matucci‐Cerinic, Christopher P. Denton, David Launay, É. Hachulla, (unknown)	2019	73
4	Prevalence of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: New Data From a French Cohort and a Systematic Review and Meta‐Analysis Arthritis & Rheumatology ·Vincent Sobanski, Luc Dauchet, Guillaume Lefèvre, M. Lambert, S. Morell‐Dubois, Thierno Sy, É. Hachulla, Pierre‐Yves Hatron, David Launay, Sylvain Dubucquoi	2013	71
5	Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease PLoS ONE ·N. Le Gouellec, Alain Duhamel, T. Pérez, Anne-Lise Hachulla, Vincent Sobanski, Jean‐Baptiste Faivre, S. Morell‐Dubois, M. Lambert, Pierre‐Yves Hatron, É. Hachulla, Hélène Béhal, Régis Matran, David Launay, Martine Rémy-Jardin	2017	66
6	Altered B lymphocyte homeostasis and functions in systemic sclerosis Autoimmunity Reviews ·Alexandra Forestier, Thomas Guerrier, Mathieu Jouvray, Jonathan Giovannelli, Guillaume Lefèvre, Vincent Sobanski, Carine Hauspie, É. Hachulla, Pierre‐Yves Hatron, Hélène Zéphir, Patrick Vermersch, Myriam Labalette, David Launay, Sylvain Dubucquoi	2018	65
7	Characteristics and Survival of Anti–U1 RNP Antibody–Positive Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension Arthritis & Rheumatology ·Vincent Sobanski, Jonathan Giovannelli, Bernadette Lynch, Benjamin Schreiber, Svetlana I. Nihtyanova, Jennifer Harvey, Clive Handler, Christopher P. Denton, Gerry Coghlan	2015	65
8	Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity Lupus ·Cécile Yelnik, G. Urbanski, Élodie Drumez, Vincent Sobanski, Hélène Maillard, Aurélia Lanteri, S. Morell‐Dubois, Claudine Caron, Sylvain Dubucquoi, David Launay, Alain Duhamel, É. Hachulla, P.Y. Hatron, M. Lambert	2016	59
9	Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis PLoS ONE ·David Launay, David Montani, Paul M. Hassoun, Vincent Cottin, Jérôme Le Pavec, Pierre Clerson, Olivier Sitbon, Xavier Jaïs, Laurent Savale, Jason Weatherald, Vincent Sobanski, Stephen C. Mathai, Mājid Shafiq, Jean-François Cordier, É. Hachulla, Gérald Simonneau, Marc Humbert	2018	45
10	Role of B cells in the pathogenesis of systemic sclerosis La Revue de Médecine Interne ·Sébastien Sanges, Thomas Guerrier, David Launay, Guillaume Lefèvre, Myriam Labalette, Alexandra Forestier, Vincent Sobanski, J. Corli, Carine Hauspie, Manel Jendoubi, Ibrahim Yakoub‐Agha, Pierre‐Yves Hatron, É. Hachulla, Sylvain Dubucquoi	2016	44
11	Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Current Rheumatology Reports ·Vincent Sobanski, David Launay, É. Hachulla, Marc Humbert	2016	33
12	Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity Autoimmunity Reviews ·Aurélia Lanteri, Vincent Sobanski, Carole Langlois, Guillaume Lefèvre, Carine Hauspie, Sébastien Sanges, M. Lambert, S. Morell‐Dubois, Pierre‐Yves Hatron, É. Hachulla, David Launay, Sylvain Dubucquoi	2014	31
13	Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis? Frontiers in Immunology ·Aurélien Chepy, Louisa Bourel, Vincent Koether, David Launay, Sylvain Dubucquoi, Vincent Sobanski	2022	30
14	Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome PLoS ONE ·David Launay, Virginie Dutoit-Lefèvre, Emmanuel Faure, Olivier Robineau, Carine Hauspie, Vincent Sobanski, É. Hachulla, Myriam Labalette, Pierre‐Yves Hatron, Sylvain Dubucquoi	2013	27
15	Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross‐Sectional Study Arthritis & Rheumatology ·Alain Lescoat, Cécile Yelnik, Guillaume Coiffier, Matthieu Wargny, Christophe Lamotte, C. Cazalets, Nicolas Belhomme, Alice Ballerie, Pierre‐Yves Hatron, David Launay, Aleth Perdriger, Vincent Sobanski, É. Hachulla, P. Jégo	2018	26
16	18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study Arthritis Research & Therapy ·Emmanuel Ledoult, Maxime Morelle, Michaël Soussan, A. Mékinian, Hélène Béhal, Vincent Sobanski, É. Hachulla, D. Huglo, N. Le Gouellec, Martine Rémy-Jardin, C. Baillet, David Launay	2021	23
17	Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis Arthritis Research & Therapy ·(unknown), Emmanuel Ledoult, David Launay, Hélène Behal, Luc Mouthon, G. Pugnet, Jean‐Christophe Lega, C. Agard, Yannick Allanore, P. Jégo, A.L. Fauchais, Jean‐Robert Harlé, S. Berthier, Achille Aouba, A. Mékinian, Élisabeth Diot, Marie‐Elise Truchetet, Carine Boulon, Alain Duhamel, É. Hachulla, Vincent Sobanski	2020	22
18	Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors Seminars in Arthritis and Rheumatism ·Alexandra Forestier, N. Le Gouellec, Hélène Behal, Gerdien Kramer, T. Pérez, Vincent Sobanski, Sandrine Morell Dubois, M. Lambert, Pierre‐Yves Hatron, É. Hachulla, Alain Duhamel, Régis Matran, David Launay, Martine Rémy‐Jardin	2020	21
19	The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological disorder The Lancet Rheumatology ·Alain Lescoat, Catherine Cavalin, Rodney Ehrlich, C. Cazalets, Alice Ballerie, Nicolas Belhomme, Guillaume Coiffier, M. De Saint Riquier, Paul-André Rosental, É. Hachulla, Vincent Sobanski, P. Jégo	2019	19
20	Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis PLoS ONE ·N. Sivova, David Launay, Lidwine Wémeau-Stervinou, Pascal de Groote, Martine Rémy-Jardin, Guillaume Denis, M. Lambert, Nicolas Lamblin, S. Morell‐Dubois, Marie Fertin, Guillaume Lefèvre, Vincent Sobanski, Olivier Le Rouzic, Pierre‐Yves Hatron, B. Wallaert, É. Hachulla, T. Pérez	2013	19

About Vincent Sobanski

Vincent Sobanski is a scholar working on Pathology and Forensic Medicine, Epidemiology, Pulmonary and Respiratory Medicine, Immunology and Rheumatology, having authored 77 papers that have together received 1.3k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (50 papers), Inflammatory Myopathies and Dermatomyositis (23 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Pulmonary Hypertension Research and Treatments (13 papers), Mast cells and histamine (9 papers), Systemic Lupus Erythematosus Research (9 papers), Autoimmune Bullous Skin Diseases (8 papers) and Connective Tissue Growth Factor Research (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (919 citations), Dermatology (201 citations), Pulmonary and Respiratory Medicine (609 citations), Rheumatology (245 citations) and Immunology (266 citations). Vincent Sobanski has collaborated with scholars based in France, United States and Germany. Frequent co-authors include David Launay, É. Hachulla, Pierre‐Yves Hatron, Marc Humbert, M. Lambert, Guillaume Lefèvre, Sylvain Dubucquoi, Luc Dauchet, S. Morell‐Dubois and Jonathan Giovannelli. Their work appears in journals such as Frontiers in Immunology, PLoS ONE, Autoimmunity Reviews, Arthritis & Rheumatology and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Vincent Sobanski

Impact in

Papers in i

In The Last Decade

Vincent Sobanski

Peers

Countries citing papers authored by Vincent Sobanski

Fields of papers citing papers by Vincent Sobanski

All Works

About Vincent Sobanski

Explore authors with similar magnitude of impact

Papers in